Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
Pharmacology effect
antikoagulanciá fibrinolytiká
Pharmacology effect
Anticoagulants Fibrinolytic Agents
Links
(46) - ARTICLES
(8) - CiBaMed
(1) - BOOKS
subject heading
openseadragon
Number of the records: 1
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.
